| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022835 |
| Receipt No. | R000026317 |
| Official scientific title of the study | Patient survey using BreastQ Reconstruction module (Japanese edition) |
| Date of disclosure of the study information | 2016/07/30 |
| Last modified on | 2016/06/22 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Patient survey using BreastQ Reconstruction module (Japanese edition) | |
| Title of the study (Brief title) | Patient survey using BreastQ | |
| Region |
|
|
| Condition | ||
| Condition | Breast Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We investigate patients satisfaction by BreastQ for the patients who underwent breast reconstruction . |
| Basic objectives2 | Others |
| Basic objectives -Others | The objective of this study was to compare the satisfaction of breast reconstruction in implant-based reconstruction versus autologus reconstruction. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Patients satisfaction by BreastQ |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | BreastQ | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patient of breast reconstruction | |||
| Key exclusion criteria | Those whom we considre inappropiate due to physical and/or mental problem | |||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Yukiko Kuramoto |
| Organization | Cancer Institute Hospital |
| Division name | Department of Plastic and Reconstructive Surgery |
| Address | 3-8-31 Ariake, Koutou-ku, Tokyo, 135-8550 Japan |
| TEL | 03-3520-0111 |
| yukiko.kuramoto@jfcr.or.jp | |
| Public contact | |
| Name of contact person | Yukiko Kuramoto |
| Organization | Cancer Institute Hospital |
| Division name | Department of Plastic and Reconstructive Surgery |
| Address | 3-8-31 Ariake, Koutou-ku, Tokyo, 135-8550 Japan |
| TEL | 03-3520-0111 |
| Homepage URL | |
| yukiko.kuramoto@jfcr.or.jp | |
| Sponsor | |
| Institute | Cancer Institute Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Cancer Institute Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026317 |